Carver Biosciences
Boston · Founded 2022
About Carver Biosciences
Carver Biosciences is a biotech company focused on the development of CRISPR/Cas13 antivirals.
Company Facts
- Founded: 2022
- Legal name: Carver Biosciences Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: carver.bio
Social Profiles
Canonical: https://fsome.com/organization/carver-biosciences-8349012 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.